vidence from a well-powered clinical trial, 1,2 as well as a systematic review and a meta-analysis, 3 supports the efficacy of osteopathic manual treatment for low back pain. 4 The mechanisms of action, however, are poorly understood. Animal models are needed to investigate the mechanisms of manual therapies (MTs) such as osteopathic manipulative treatment, but testing manipulation in animal models is problematic because reduction of pain, the endpoint associated with many osteopathic treatments, is a subjective experience that animals cannot describe and that investigators cannot directly measure in animals. Therefore, pain must be assessed indirectly by observing pain-related behavior.
housed in wheel cages. Opaque barriers were placed between cages to minimize the influence of an adjacent rat's activity on each rat's running behavior. Because virtually all running occurs during the dark cycle, 14 wheel revolutions were recorded daily within 4 hours after the beginning of the light cycle for the convenience of the investigators, as very little running occurred after the end of the dark cycle. Each wheel revolution measured 1 meter.
All rats exhibited inherent running behavior. Although all rats increased their daily running over time, rats that ran relatively more continued to outperform other rats, whereas rats that ran relatively less continued to underperform compared with other rats. To control for this inherent behavior, we recorded the initial 3 days of running data and ranked rats by total 3-day baseline running distance to group rats with similar running distances ( Figure 1 ). Then we used blocked randomization to assign rats to groups in which blocks were determined by baseline running. The number of rats in each block was equal to the number of treatment groups. For example, to compare the effects of morphine with that of saline, the 2 rats with the lowest baseline running distance were paired, and then the next 2, and so on. One rat in each pair was randomly assigned to receive morphine, and the other rat was assigned to receive saline.
Experimental Design
After the 3-day baseline running distance was established for each rat, the ankle joints of some rats were injected with carrageenan (injured) and treated with MT or analgesic medications. Several forms and doses of MT were tested. Of the 3 classes of medications that are appropriate for managing acute pain-opioids, NSAIDs, and steroids-one analgesic medication from each class (morphine, an opioid; ketorolac, an NSAID; and prednisone, a corticosteroid) was selected to test for use as a positive control. After treatment, rat running was monitored for an additional 6 to 10 days.
In the preliminary experiments, rats ran for 3 days to Angeby-Möller et al 9 and Buvanendran et al 10 tracked
pain-related behavior in rodents by measuring voluntary locomotion and weight bearing. These measures are objective, with easily assessed endpoints that can be measured by means of cages outfitted with photosensors 9 or pressure-sensitive devices, 10 or by using subjective analyses of video recordings of the rodents. 11 Cobos et al 12 used activity wheels to measure locomotion. In the current study, we used activity wheels because they were relatively inexpensive and yielded objective endpoints that were easy to record.
Classes of medications appropriate for treating acute pain include opioids, steroids, and non-steroidal antiinflammatory drugs (NSAIDs). 13 In the current study, we examined each of these medications as a potential positive control.
The objective of the current study was to assess the effect of MT on the function of rats with an inflamed joint compared with rats with an inflamed joint that were not treated. We hypothesized that rats with inflammatory joint injury would run less and that MT and analgesic medications would improve running distance compared with that of injured, untreated rats.
Methods

Animals
All experiments were approved by the local Animal Care On arriving at the animal facility, rats were allowed to acclimatize 2 days to 2 weeks before being placed in polycarbonate cages that contained activity wheels connected to digital display counters to establish baseline running (Thermo Fisher Scientific). Rats were singly up to 10 days. Pharmaceutical agents were administered as a single dose. Morphine was administered either the evening of the injection day (ie, early morphine) or the following morning (ie, late morphine). Ketorolac was administered the morning after carrageenan injection.
Prednisone was administered the evening of injection day. Rats that were treated with morphine or ketorolac, which do not persist in the body, were followed for up to 24 hours after treatment. Rats treated with prednisone, which is long acting, were followed for 10 days. To control for the potential therapeutic effect of exercise, we conducted 2 experiments with an enforced sedentary collect baseline running data, were injected with carrageenan, and then were monitored for daily running for up to 10 days ( Figure 1A ). Uninjured control rats did not receive carrageenan injection. In the primary experiments, rats ran for 3 days to collect baseline running data, were injected with carrageenan in the morning, were treated with either MT or with an analgesic medication, and were monitored for daily running for up to 10 days ( Figure 1B and Figure 1C ). Injured controls received no touch or vehicle. Two sessions of MT were performed, the first on the evening of the injection day and the second on the following evening. Rats were followed for neously the morning after carrageenan injection. Uninjured controls received no injection because injection alone has no effect on running behavior.
Preliminary Experiments
The 7 preliminary experiments are described in Table 2 and illustrated in Figure 1A . The first preliminary experiment was conducted to assess inherent running variability. Both 3-day baseline running and injection-day running were recorded and correlated to 10-day running after injection. To test the influence of the barriers, data from our pilot studies, which were performed without barriers, were compared with the current experiments, which used barriers. To determine whether injury was caused by the needle (negative control), in 1 experiment rats received either an intra-articular injection of 0.9% saline (pH 7.4) or no injection. To determine the optimal dose required to induce inflammation, rats were injected with 0.05 mL of 0.75%, 1.5%, or 3% carrageenan as described previously.
To assess whether swelling correlated with running, the basic experimental design was used but with no MT or analgesic treatment ( Table 2) 
Primary Experiments
The 5 primary experiments (Table 3 ) were designed to control for numerous variables that could influence the outcomes in the rat model of the current study. The first experiment was to determine the optimal duration flamed ankles. 6 Flexion and extension were performed at a frequency of 20 times per minute. Ankle oscillation ( Table 1 We injected ketorolac (catalog #K1136, Sigma Aldrich) at 20 mg/kg body weight in 0.3 mL distilled water intraperitoneally the evening after carrageenan injection.
Injured control rats for the ketorolac treatment received an intraperitoneal injection of 0.3 mL water alone at the same time.
Prednisone (catalog #1559006, Fisher Scientific), 0.05 mL of 30 mg/mL in ethanol, was injected subcuta-after sprain. 15 Running wheels were immobilized immediately after injury to create a 4-day sedentary period.
Wheel mobility was restored at the end of the sedentary period so rats could resume running. We performed MT for 2 minutes with 1 minute of rest for 2 repetitions ( Inherent running Baseline running and injection day running were recorded to determine variability if data were predictive of cumulative running.
Barriers
Opaque barriers were compared with no barriers to assess effect on running behavior.
Saline or no injection Running behavior was compared after either saline injection or no as a negative control injection to determine if injury was caused by the needle during injection. Running behavior after carrageenan injection was also compared with running after saline injection or no injection.
Carrageenan dose The effects of 3 doses of carrageenan on running behavior were tested to determine the optimal carrageenan dose.
Carrageenan and
The effect of carrageenan on swelling was recorded the day after injection swelling (1 day) to determine whether initial swelling correlated with running behavior.
The effect of carrageenan on swelling was recorded daily after injection swelling (1 week) for 7 days to determine whether a decrease in swelling correlates with an increase in running behavior.
Analgesic medications Morphine, ketorolac, and prednisone were evaluated for use as positive controls. Table 3 .
List of Primary Experiments Performed on Rats Experiment Description
Duration of manual To determine the optimal dose of MT, 2 or 3 repetitions of a therapy (MT) 3-minute MT protocol with 1-minute rest periods were compared.
Sedentary Period An enforced 4-day sedentary period with MT during the first 2 days or the last 2 days of the sedentary period was included to control for the potential therapeutic effect of exercise.
MT with ankle Ankle effleurage was performed with knee MT to increase effleurage lymph drainage.
Ankle MT Ankle MT with ankle effleurage was performed to treat the injured joint directly.
Bilateral injury Both ankles were injected with carrageenan, and MT was applied to both knees to control for the ability of rats to compensate for injury.
ance was also used to test for differences in swelling between treatment and vehicle. SAS 9.3 (SAS Institute Inc) was used for the statistical analyses. We set statistical significance at P⩽.05.
Results
Preliminary Experiments
For inherent running variability, 3-day baseline running distance was more strongly related to subsequent running in injured rats (ρ=0. Saline injection and no injection as controls gave the same results; saline did not affect running distance (P>.30; Figure 2A ). Carrageenan injection reduced running ( Figure 2B ). The day after injection, rats injected with carrageenan ran 9% of the distance that uninjured controls (which received saline injection or no injection) ran (P<.001). The running of injured rats increased each day relative to uninjured controls. By 4 days after injection, rats reached their pre-injection running distance, and by 5 days after injection they caught up to the running distances of uninjured controls. There was no dosedependent effect of carrageenan for the 3 doses from 0.75% to 3% carrageenan (P=.26; Figure 2B ). The running behavior of all injected but untreated rats from all of the experiments is shown in Figure 2C .
Carrageenan induced visible hindlimb swelling as seen in a 55% increase in volume (P=.002) and a 64% increase in diameter (P=.004) after 24 hours (Figure 3) . 
Statistical Analyses
Spearman correlation coefficients were used to determine whether baseline running or injection day running was more strongly related to 10-day running and whether Figure 5 , and Table 1 ).
However, some investigators noted that joint stiffness in rats was reduced after treatment.
Rats with bilateral injuries ran fewer revolutions than rats injured in 1 ankle only (ie, unilaterally), running 2.5% of the distance unilateral injury rats ran the day after injection and gaining up to 48% of the distance run by unilateral injury rats 7 days after injection (P<.01).
Protocol 6-MT administered to both injured knees of the rats (Table 1) -did not significantly affect the running behavior of injured rats compared with injured notouch control rats (P=.47) ( Figure 5C ).
jection or saline-injected rats after 24 hours (P>.31). There were no statistically significant differences for any of the pharmaceutical agents compared with no treatment for running ( Table 4 and Table 5 ) or hindlimb swelling (data not shown). 
Comment
In the current study, we intended to identify a successful MT model in rats and to lay the groundwork for subsequent studies that could be performed to delineate underlying therapeutic mechanisms for MT. We established that carrageenan injected into the ankle induced an inflammatory injury in the joint, which reliably compromised activity wheel use. A meta-analysis of clinical trials 16 observed that a variety of MT techniques yielded better results than mobilization alone, so the current study used a variety of MT techniques. In our subjective assessment, we found that MT and ankle effleurage were sufficient to loosen the treated joint whether MT was applied to the proximal joint (the knee) or the injured joint (the ankle);
greater flexibility in either joint indicated a physiologic response to the treatment. Clinically, mobilization and range-of-motion exercises reduce pain and recovery time after ankle sprain. 17, 18 In the current study, however, the effect of MT, no matter the location or duration of treatment, and the effects of analgesic medications on running wheel activity were not apparent.
Our research design and MT protocols directed to the knee were based on studies by Skyba et al, 6 Sluka et al, 7 and Sluka and Wright, 8 pathways. 6 In the current study, we initially used capsaicin at the same and greater concentration levels as cator of nociception. Voluntary running wheel activity was shown to decrease after carrageenan was injected into the hindpaw 12 and after monosodium iodoacetate was injected into the knee to induce osteoarthritis. 22 In the current study, voluntary running wheel activity consistently demonstrated decreased 24-hour running distance after carrageenan was injected into the ankle.
Modeling our methods on those of Sluka and Wright, 8 we injected carrageenan into the ankle to create inflammatory injury, and we treated the proximal joint. Rats ran very little the first night after carrageenan injection, but on each subsequent night they ran more, catching up to their uninjured counterparts within 5 days. This progression is clinically relevant: after a grade 1 ankle sprain, on average, human patients return to full weight bearing when walking at 6 days after injury, and return to normal pre-injury walking rates after 11 days. 23 In the current study, mobilization to the knee did not affect the course of recovery, and so the MT was modified to include effleurage, a lymphatic drainage technique, which was performed on the injected ankle, an approach more consistent with current osteopathic treatment models. Again, we did not observe a beneficial effect on running behavior. These approaches did not influence the running characteristics of rats with inflamed ankles. Ideally, rats would be fully separated to eliminate the efof the medications influenced running behavior to a statistically significant level. We did not anticipate this outcome, because previous reports indicate that morphine and ketorolac at similar doses (1 mg/kg and 20 mg/ kg body weight, respectively) restored reduced activity in photosensor cages after knee surgery 10 and morphine restored activity wheel running after carrageenan injection into the hindpaw.
12
A 2012 study of mice 12 showed that several analgesic medications, some of which we used in the current study, were effective in restoring running behavior after an intraplantar injection of complete Freund's adjuvant. 12 This result suggests that running behavior in rodents may be a useful endpoint when the injury is on the surface of the paw. Some studies 9, 10, 25 show an effect of analgesics in restoring locomotion after joint injury. Pharmaceutical agents, including morphine, partially reversed the reduction in grip force caused by osteoarthritis induced by sodium monoiodoacetate (ie, monosodium iodoacetate). 25 Buvanendran et al 10 The MT techniques we developed for the rat knee and ankle were easily taught to second-year osteopathic medical students. Involving students increased the number of experiments we could perform and had the benefit of exposing students to osteopathic medical research. One disadvantage of multiple investigators, however, was the possibility of variability, but we tried to control for this by observing students' techniques throughout the experiment to minimize inconsistency.
Investigator bias was not observed to impact running distance.
A limitation of our study is that joint stiffness, the feedback that we used to modify MT technique, was not quantifiable. Every investigator independently noted that the joint began to loosen after 2 minutes of treatment and that the treated joints were less stiff immediately after treatment and 24 hours after the first treatment, compared with injured joints that did not receive treatment.
For this reason, it was helpful to have multiple investigators participate in performing MT. Unfortunately, we were unable to find a reliable, repeatable method to measure joint stiffness. We initially tried to quantify joint stiffness by means of a force transducer or with weights that straighten the limb, 29 but we were unsuccessful. Because the quantifiable endpoint we used-running wheel activity-was not influenced by any of the treatments we tested, a valid, meaningful, and quantifiable endpoint must be found before further studies can be undertaken using this animal model. Correlation of activity wheel running and hindlimb swelling in rats (n=32) after 3% carrageenan injection as measured by caliper before and after injection. The increase in hindlimb diameter 24 hours after injection was plotted vs the number of revolutions run in the same period (ρ=−0.07, P=.68). Abbreviation: ρ, Spearman rank correlation coefficient. 
